drug protocol number

IRB#17-329 version2

drug sponsor

King Abdullah Medical City, Makkah

drug study

Capecitabine / oxaliplatin / FOLINIC Acid / FLUOROURACIL

drug trial site

KAMC

drug status

Ongoing

drug phase